Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia

BACKGROUND: Acquired aplastic anemia results from immune-mediated destruction of bone marrow. Immunosuppressive therapies are effective, but reduced numbers of residual stem cells may limit their efficacy. In patients with aplastic anemia that was refractory to immunosuppression, eltrombopag, a synt...

Full description

Saved in:
Bibliographic Details
Published in:N Engl J Med
Main Authors: Townsley, Danielle M., Scheinberg, Phillip, Winkler, Thomas, Desmond, Ronan, Dumitriu, Bogdan, Rios, Olga, Weinstein, Barbara, Valdez, Janet, Lotter, Jennifer, Feng, Xingmin, Desierto, Marie, Leuva, Harshraj, Bevans, Margaret, Wu, Colin, Larochelle, Andre, Calvo, Katherine R., Dunbar, Cynthia E., Young, Neal S.
Format: Artigo
Language:Inglês
Published: 2017
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5548296/
https://ncbi.nlm.nih.gov/pubmed/28423296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1613878
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items